Senior insider sale
SVP and General Counsel at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$506.3K
20.31K shares
What this filing means
MATSUDA MASARU plans to sell 20.31K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $506.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001628280-26-029919
Officer· SVP and General Counsel
Since Jan 2022
20.31K
Shares to sell
$506.3K
Approx. market value
8.26K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
NA
5/1/2026
884.00Restricted Stock Vesting
NA
11/14/2025
2.22KRestricted Stock Vesting
NA
5/1/2025
5.15KTotal acquired8.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Restricted Stock Vesting NA | 884.00 | — |
11/14/2025 | Restricted Stock Vesting NA | 2.22K | — |
5/1/2025 | Restricted Stock Vesting NA | 5.15K | — |
| Total | 8.26K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
8.73K
Market value
$220.9K
3/2/2026
—Completed
Units to sell
3.33K
Market value
$92.9K
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.26K
Market value
$192.4K
5/4/2026
Total
Units
20.31K
Value
$506.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 8.73K | $220.9K | — | Completed |
2/27/2026 | 3.33K | $92.9K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 8.26K | $192.4K | NASDAQ | Planned |
| Total | 20.31K | $506.3K | ||